Sidney Farber and the treatment of childhood acute lymphoblastic leukemia with a chemotherapeutic agent

Pediatr Hematol Oncol. 2012 May;29(4):299-302. doi: 10.3109/08880018.2012.678969.

Abstract

Acute lymphoblastic leukemia (ALL) is the most common malignancy affecting children accounting for approximately 30% of childhood cancers, which was uniformly fatal before the advent of effective chemotherapy. In this historical note, the fundamental contribution of Sidney Farber to the treatment of ALL by using, for the first time, aminopterin-a chemotherapeutic agent-has been recognized.

Publication types

  • Historical Article
  • Review

MeSH terms

  • Aminopterin* / history
  • Aminopterin* / therapeutic use
  • Antineoplastic Agents* / history
  • Antineoplastic Agents* / therapeutic use
  • Child
  • Child, Preschool
  • Folic Acid Antagonists* / history
  • Folic Acid Antagonists* / therapeutic use
  • History, 19th Century
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / history

Substances

  • Antineoplastic Agents
  • Folic Acid Antagonists
  • Aminopterin